This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2023.
Company Filing History:
1 out of 834,411 Years Active: 2023
Title: Fazila Rizvi: Innovator in Alzheimer's Research
Introduction
Fazila Rizvi is a notable inventor based in Karachi, Pakistan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating Alzheimer's Disease. Her innovative work focuses on the inhibition of the butyrylcholinesterase enzyme, which is linked to the progression of Alzheimer's.
Latest Patents
Fazila Rizvi holds a patent for "Derivatives of 4-aminoantipyrine as anti-Alzheimer's butyrylcholinesterase inhibitors." This invention involves the treatment of diseases associated with increased butyrylcholinesterase enzyme activity, specifically Alzheimer's Disease. The patent details the administration of effective amounts of new N, N'-disubstituted benzylamine derivatives of 4-aminoantipyrine. Kinetic studies of two potent compounds revealed their potential as competitive and non-competitive inhibitors of BuChE.
Career Highlights
Throughout her career, Fazila Rizvi has demonstrated a strong commitment to research and innovation. Her work has led to the identification of new compounds that could play a crucial role in Alzheimer's treatment. The findings from her studies have the potential to contribute significantly to the pharmaceutical field.
Collaborations
Fazila has collaborated with colleagues such as Atia-tul-Wahab and Hina Siddiqui. These partnerships have enhanced her research efforts and contributed to the advancement of her innovative projects.
Conclusion
Fazila Rizvi is a pioneering inventor whose work in Alzheimer's research showcases her dedication to improving healthcare through innovation. Her contributions to the field are invaluable and highlight the importance of continued research in combating neurodegenerative diseases.